Market revenue in 2021 | USD 6.0 million |
Market revenue in 2030 | USD 47.6 million |
Growth rate | 25.9% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.33% in 2021. Horizon Databook has segmented the UAE ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
In the UAE, the clinical research sector is performing well, with many pharmaceutical companies investing in studies. Phase three and phase four studies are most common in the UAE along with observational studies.
The regulatory scenario in the country is favorable for clinical studies. The Health Authority Abu Dhabi (HAAD) medical research sections promote world-class research that improves health & quality of life while ensuring ethical conduct of research & protection of human subjects.
These factors are expected to boost the market growth. These factors are further supporting growth and adoption of AIbased solutions for enhanced clinical research, timely results, and reduction in overall clinical trials cost.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into UAE ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account